Bayer AG NA

Bayer AG NA

BAYN · XETRA · Healthcare / Drug Manufacturers - General

56.52EUR-0.04 (-0.07%)

Price History

Full chart

Market Stats

Previous Close56.56
Open56.52
Day Range56.40 – 56.98
52-Week Range25.71 – 53.92
Volume1.89M
Market Cap44.15B
P/E (TTM)0.00
Forward P/E10.64
EPS-1.76
Dividend Yield0.24%
Beta0.83
50-Day Avg48.59
200-Day Avg43.03

About

Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft has a strategic alliance with The University of Colorado Anschutz, along with UCHealth and Children's Hospital Colorado to advance drug development and clinical trials. Bayer Aktiengesellschaft has a strategic alliance Henry Ford Health. It has a commercial agreement with Neste to Jointly scale newgold winter canola for biofuels production. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - General
  • CEOMr. William N. Anderson
  • Employees87.83K
  • HeadquartersKaiser-Wilhelm-Allee 1, Leverkusen, Germany, 51368, Germany
  • Websitehttps://www.bayer.com

Leadership

  • Mr. William N. AndersonChairman of the Management Board & CEO · b. 1966
  • Mr. Stefan OelrichPresident of the Pharmaceuticals Division & Member of the Board of Management · b. 1968
  • Ms. Heike PrinzChief Talent Officer, Labor Director & Member of Management Board · b. 1964
  • Dr. Judith HartmannCFO & Member of Management Board · b. 1969
  • Mr. Rodrigo SantosMember of Management Board, Head of the Crop Science Division & President of Crop Science Division · b. 1973
  • Mr. Julio TrianaMember of Management Board & President of Consumer Health Division · b. 1965
  • Mr. Alex BuschermohleChief Information Officer, Head-Digital Transformation & IT-Crop Science Division
  • Ms. Jana Marlen AckermannHead of the Investor Relations · b. 1984
  • Mr. Bill DoderoGeneral Counsel and Senior VP of Law Patents & Compliance
  • Mr. Michael PreussHead of Communications, Government Relations and Corporate Brand

Financials

Income Statement

Currency: EUR1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue28.06B27.32B29.56B28.99B28.98B28.52B23.28B24.70B28.96B32.38B32.92B31.17B35.09B36.53B39.74B40.16B41.34B46.09B34.94B35.02B36.74B43.55B41.40B44.08B50.74B47.64B46.61B45.58B
Growth (%)--2.64%+8.20%-1.94%-0.01%-1.61%-18.37%+6.11%+17.23%+11.84%+1.65%-5.32%+12.58%+4.10%+8.80%+1.05%+2.94%+11.48%-24.18%+0.21%+4.93%+18.52%-4.93%+6.48%+15.10%-6.11%-2.16%-2.21%
Cost of Revenue12.51B13.59B15.61B16.57B17.53B16.80B12.57B13.34B15.09B16.07B16.46B15.13B17.10B17.98B19.07B19.52B19.91B21.04B11.76B11.38B15.38B17.61B19.14B16.82B19.87B19.75B21.27B18.59B
Gross Profit15.55B13.73B13.95B12.42B11.46B11.71B10.71B11.37B13.87B16.32B16.46B16.03B17.98B18.55B20.67B20.64B21.43B25.05B23.19B23.63B21.36B25.93B22.26B27.27B30.87B27.89B25.34B26.98B
Gross Margin55.42%50.27%47.20%42.83%39.54%41.07%46.00%46.01%47.90%50.39%50.01%51.44%51.26%50.79%52.01%51.40%51.84%54.35%66.36%67.49%58.14%59.55%53.77%61.85%60.84%58.54%54.36%59.21%
Operating Expense12.40B10.38B10.81B11.17B9.88B12.91B9.03B8.81B10.73B11.36B12.91B12.97B14.73B13.97B15.38B15.90B15.93B18.76B17.48B17.75B19.97B20.72B22.25B19.34B22.63B19.48B20.86B20.03B
Operating Income3.15B3.36B3.14B1.24B1.58B-1.20B1.68B2.56B3.15B4.96B3.55B3.06B3.26B4.58B5.29B4.74B5.50B6.28B5.70B5.89B1.39B5.21B12.00M7.93B8.24B8.41B4.48B6.95B
Operating Margin11.24%12.29%10.63%4.29%5.43%-4.21%7.20%10.34%10.86%15.30%10.79%9.82%9.28%12.55%13.30%11.80%13.31%13.63%16.32%16.82%3.77%11.97%0.03%17.99%16.24%17.65%9.61%15.26%
EBITDA9.14B6.59B5.29B4.13B4.89B3.53B3.81B4.31B5.38B7.43B6.12B5.72B5.80B7.11B7.93B7.35B8.20B9.38B8.05B8.03B4.28B9.65B4.29B7.02B10.29B4.05B3.67B2.65B
EBITDA Margin32.57%24.14%17.88%14.26%16.88%12.37%16.37%17.46%18.57%22.95%18.59%18.36%16.52%19.45%19.95%18.31%19.83%20.36%23.05%22.93%11.65%22.17%10.37%15.92%20.29%8.50%7.89%5.81%
Net Income1.61B2.00B1.67B966.56M1.06B-1.26B752.00M1.38B1.51B2.30B1.72B1.36B1.30B2.47B2.40B3.19B3.43B4.11B4.53B7.34B1.70B4.09B-10.49B1.00B4.15B-2.94B-2.55B-3.62B
Net Income Margin5.75%7.33%5.63%3.33%3.66%-4.41%3.23%5.57%5.23%7.11%5.21%4.36%3.71%6.76%6.05%7.94%8.29%8.92%12.97%20.95%4.61%9.39%-25.35%2.27%8.18%-6.17%-5.48%-7.94%
R&D1.81B2.14B2.38B2.49B2.53B2.41B1.93B1.73B2.30B2.58B2.65B2.75B3.05B2.93B3.01B3.19B3.54B4.27B4.41B4.50B5.11B5.30B7.13B5.41B6.57B5.37B6.21B5.77B
R&D as % of Total Revenue6.45%7.84%8.05%8.60%8.74%8.45%8.28%7.00%7.93%7.96%8.06%8.81%8.70%8.03%7.58%7.95%8.56%9.27%12.61%12.86%13.89%12.17%17.21%12.28%12.95%11.27%13.32%12.66%
Interest Expense000000656.00M909.00M1.38B1.32B948.00M815.00M690.00M726.00M558.00M584.00M611.00M751.00M690.00M1.06B1.55B1.63B1.39B1.23B1.67B1.74B1.96B1.72B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%2.82%3.68%4.77%4.08%2.88%2.61%1.97%1.99%1.40%1.45%1.48%1.63%1.97%3.03%4.21%3.75%3.36%2.79%3.30%3.64%4.20%3.78%

Balance Sheet

Currency: EUR1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets29.38B31.28B36.55B37.10B41.73B37.38B37.78B36.69B55.89B51.38B52.51B51.04B51.51B52.77B51.34B51.32B70.23B73.92B82.24B75.09B126.28B126.26B117.05B120.24B124.88B116.26B110.85B110.61B
Total Liabilities16.60B16.10B20.13B20.05B26.26B25.07B25.41B25.79B43.04B34.56B36.17B32.09B32.61B33.49B32.77B30.51B50.02B48.47B50.34B38.23B80.14B78.74B86.35B87.07B85.95B83.18B78.81B84.54B
Total Equity12.57B15.01B16.19B16.95B15.35B12.19B12.26B10.82B12.77B16.73B16.26B18.90B18.83B19.21B18.47B20.72B20.11B24.27B30.33B36.80B45.98B47.34B30.52B33.02B38.77B32.93B31.91B25.95B
Cash--491.91M720.43M768.09M2.73B3.57B3.29B2.91B2.53B2.09B2.73B2.84B1.77B1.70B1.66B1.85B1.86B1.90B7.58B4.05B3.19B4.19B4.56B5.17B5.91B6.19B6.67B
Total Debt4.73B4.47B6.68B7.39B10.17B9.41B9.72B8.55B14.43B13.80B15.70B12.10B11.04B10.92B8.91B7.20B19.24B18.80B18.26B13.21B40.67B38.88B41.56B39.53B41.65B44.79B40.74B37.44B
Net Debt4.73B4.47B6.19B6.67B9.40B6.68B6.15B5.27B11.51B11.27B13.61B9.38B8.20B9.15B7.22B5.54B17.39B16.94B16.36B5.63B36.61B35.70B37.36B34.97B36.48B38.88B34.55B30.77B

Cash Flow

Currency: EUR1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow2.85B3.25B3.10B3.87B4.42B3.29B2.45B3.50B4.20B4.28B3.61B5.38B5.77B5.06B4.53B5.17B5.81B6.89B9.09B8.13B7.92B8.21B4.90B5.09B7.09B5.12B7.37B4.57B
Investing Cash Flow-3.19B214.00M-6.21B-2.14B-6.58B458.95M-813.66M-1.74B-14.73B3.19B-3.09B-1.13B-2.41B-3.89B-818.00M-2.58B-15.54B-2.76B-8.73B-432.00M-34.15B-671.00M-4.07B855.00M-2.38B-4.01B164.00M-1.61B
Financing Cash Flow-201.00M-1.73B770.87M-1.51B2.21B-1.76B-760.55M-1.88B10.20B-7.73B-873.00M-3.62B-3.23B-2.21B-3.78B-2.54B9.74B-3.97B-350.00M-1.88B23.43B-8.39B423.00M-5.64B-4.22B-679.00M-7.18B-2.19B
Capital Expenditure2.70B2.63B2.65B2.62B2.24B1.65B1.25B1.39B1.88B1.86B1.76B1.57B1.51B1.61B1.93B2.16B2.37B2.52B2.58B2.37B2.59B2.65B2.42B2.61B2.95B2.75B2.78B2.49B
Free Cash Flow145.00M621.00M445.06M1.24B2.18B1.64B1.20B2.11B2.33B2.42B1.85B3.80B4.26B3.44B2.60B3.01B3.44B4.37B6.51B5.77B5.32B5.56B2.48B2.48B4.14B2.37B4.59B2.08B
Dividends Paid712.00M770.00M956.14M1.03B662.31M662.22M558.42M439.89M534.93M773.00M1.13B973.00M1.16B1.24B1.37B1.57B1.74B1.87B2.13B2.36B2.41B2.62B2.77B1.99B1.99B2.38B131.00M127.00M
FCF to OCF5.09%19.09%14.36%32.18%49.33%49.81%48.93%60.34%55.36%56.57%51.25%70.70%73.77%68.08%57.44%58.29%59.19%63.47%71.64%70.91%67.25%67.71%50.68%48.69%58.42%46.24%62.30%45.59%
Dividend Paid to FCF491.03%123.99%214.83%82.75%30.35%40.45%46.61%20.83%22.99%31.90%60.90%25.61%27.24%36.05%52.48%52.22%50.57%42.74%32.65%40.98%45.21%47.06%111.39%80.43%47.90%100.55%2.85%6.09%

Earnings

Report DateMar 31, 2000Jun 30, 2000Sep 30, 2000Mar 31, 2001Jun 30, 2001Sep 30, 2001Dec 31, 2001Mar 31, 2002Jun 30, 2002May 5, 2003May 10, 2005Aug 10, 2005Nov 9, 2005Mar 6, 2006Apr 27, 2006Aug 1, 2006Nov 27, 2006Mar 15, 2007May 8, 2007Aug 7, 2007Nov 6, 2007Feb 28, 2008Apr 24, 2008Jul 30, 2008Oct 29, 2008Mar 3, 2009Apr 29, 2009Jul 29, 2009Oct 27, 2009Apr 29, 2010Jul 29, 2010Oct 28, 2010Feb 28, 2011Apr 28, 2011Jul 28, 2011Oct 27, 2011Feb 28, 2012Apr 26, 2012Jul 31, 2012Oct 30, 2012Feb 28, 2013Apr 25, 2013Jul 30, 2013Oct 31, 2013Feb 28, 2014Apr 28, 2014Jul 30, 2014Oct 30, 2014Feb 26, 2015Apr 30, 2015Jul 29, 2015Oct 29, 2015Feb 25, 2016Apr 26, 2016Jul 27, 2016Oct 26, 2016Feb 22, 2017Apr 27, 2017Jul 27, 2017Oct 26, 2017Feb 27, 2018May 3, 2018Sep 5, 2018Nov 13, 2018Feb 27, 2019Apr 25, 2019Jul 30, 2019Oct 30, 2019Feb 27, 2020Apr 27, 2020Aug 4, 2020Nov 3, 2020Feb 25, 2021May 12, 2021Aug 5, 2021Nov 9, 2021Mar 1, 2022May 10, 2022Aug 4, 2022Nov 8, 2022Feb 28, 2023May 11, 2023Aug 8, 2023Nov 8, 2023Mar 5, 2024May 14, 2024Aug 6, 2024Nov 12, 2024Mar 5, 2025May 13, 2025Aug 6, 2025Nov 11, 2025Mar 3, 2026May 11, 2026Jul 31, 2026Nov 3, 2026
EPS Estimate-----------------------------1.181.110.92-1.391.311.070.86-1.361.15-1.771.461.221.241.821.561.261.192.131.841.461.242.182.011.661.232.461.781.341.132.081.581.050.892.471.741.171.292.621.510.921.242.591.540.901.003.531.851.181.252.871.230.761.472.290.960.320.992.280.790.320.492.250.750.44
EPS Actual0.750.640.720.600.76-0.250.190.710.390.790.880.550.660.060.810.560.410.423.380.821.430.110.910.690.350.260.540.660.301.200.850.87-0.231.451.291.120.971.251.471.200.451.701.541.271.101.951.531.351.192.102.001.721.082.372.071.731.192.621.811.471.392.281.541.191.102.551.621.161.292.671.590.811.322.591.611.051.263.531.931.131.352.951.220.381.852.820.940.241.052.491.230.570.622.810.95-
Surprise-----------------------------1.69%-23.42%-5.43%-4.32%-1.53%4.67%12.79%-8.09%4.35%--3.95%5.48%4.10%-11.29%7.14%-1.92%7.14%0.00%-1.41%8.70%17.81%-12.90%8.72%2.99%4.22%-3.25%6.50%1.69%9.70%23.01%9.62%-2.53%13.33%23.60%3.24%-6.90%-0.85%0.00%1.91%5.30%-11.96%6.45%0.00%4.55%16.67%26.00%0.00%4.32%-4.24%8.00%2.79%-0.81%-50.00%25.85%23.14%-2.08%-25.00%5.78%9.21%55.70%78.13%26.53%25.18%26.67%-
Timing-----------------------------After-hoursAfter-hoursPre-market-Pre-marketPre-marketPre-marketPre-market-Pre-marketPre-market-Pre-marketAfter-hoursPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-market-Pre-market-Pre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap44.15B
Enterprise Value77.28B
Trailing P/E0.00
Forward P/E10.64
PEG Ratio4.72
Price / Sales0.97
Price / Book1.65
EPS-1.76
Book Value30.11
Revenue (TTM)45.38B
Gross Profit (TTM)27.43B
EBITDA10.13B
Profit Margin-3.83%
Operating Margin9.19%
Return on Equity-5.69%
Return on Assets3.18%
Shares Outstanding982.42M
Shares Float982.42M
Beta0.83
Dividend Yield0.24%
Dividend Rate0.11
Payout Ratio2.22%

Dividends

20261×
0.11Apr 27, 2026
20251×
0.11Apr 28, 2025
20241×
0.11Apr 29, 2024
20231×
2.40May 2, 2023
20221×
2.00May 2, 2022
20211×
2.00Apr 28, 2021
20201×
2.80Apr 29, 2020
20191×
2.80Apr 29, 2019
20181×
2.76May 28, 2018
20172×
2.66May 2, 20170.03Apr 28, 2017
20161×
2.46May 2, 2016
20151×
2.21May 28, 2015
20141×
2.07Apr 30, 2014
20131×
1.87Apr 29, 2013
20121×
1.62Apr 30, 2012
20111×
1.48May 2, 2011
20101×
1.38May 3, 2010
20091×
1.38May 13, 2009
20081×
1.33Apr 28, 2008
20071×
0.98Apr 30, 2007
20061×
0.93May 2, 2006
20052×
0.54May 2, 20051.35Jan 31, 2005

Stock Splits

  • Jun 6, 2018503:495
  • Jun 3, 199610:1